Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Scancell Holdings (SCLP) Share Price

Price 9.90p on 02-01-2026 at 16:40:09
Change 0.00p 0%
Buy 10.20p
Sell 9.60p
Last Trade: Buy 4,941.00 at 10.119p
Day's Volume: 80,893
Last Close: 9.90p
Open: 9.90p
ISIN: GB00B63D3314
Day's Range 9.90p - 9.90p
52wk Range: 7.25p - 12.00p
Market Capitalisation: £102.74m
VWAP: 10.07708p
Shares in Issue: 1.04b

Scancell Holdings (SCLP) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 4,941 10.119p Ordinary
16:14:10 - 02-Jan-26
Buy* 17,595 10.119p Ordinary
15:13:43 - 02-Jan-26
Buy* 4,722 9.91p Ordinary
14:38:16 - 02-Jan-26
Buy* 7,455 10.119p Ordinary
14:17:32 - 02-Jan-26
Buy* 49 10.119p Ordinary
12:17:31 - 02-Jan-26
Buy* 242 10.12p Ordinary
12:15:54 - 02-Jan-26
Sell* 10,000 9.875p Ordinary
10:55:07 - 02-Jan-26
Buy* 7,006 10.12p Ordinary
10:03:22 - 02-Jan-26
Buy* 500 10.12p Ordinary
08:48:40 - 02-Jan-26
Buy* 1,976 10.12p Ordinary
08:37:32 - 02-Jan-26
See more Scancell Holdings trades

Scancell Holdings (SCLP) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Jan 2026 (Fri) 9.90 9.90 9.90 9.90 80,893
1st Jan 2026 (Thu) 9.90 9.90 9.90 9.90 0
31st Dec 2025 (Wed) 9.90 9.90 9.90 9.90 302,135
30th Dec 2025 (Tue) 9.75 9.90 9.75 9.90 619,718
29th Dec 2025 (Mon) 9.75 9.75 9.75 9.75 106,694
26th Dec 2025 (Fri) 9.75 9.75 9.75 9.75 0
25th Dec 2025 (Thu) 9.75 9.75 9.75 9.75 0
24th Dec 2025 (Wed) 9.75 9.75 9.75 9.75 157,764
23rd Dec 2025 (Tue) 9.80 9.85 9.75 9.75 249,610
22nd Dec 2025 (Mon) 10.00 9.90 9.90 9.90 4,184,605
19th Dec 2025 (Fri) 10.20 10.20 10.00 10.00 524,685
18th Dec 2025 (Thu) 10.20 10.20 10.20 10.20 412,313
17th Dec 2025 (Wed) 10.20 10.20 10.20 10.20 646,362
16th Dec 2025 (Tue) 10.20 10.20 10.20 10.20 641,911
15th Dec 2025 (Mon) 9.95 10.20 9.95 10.20 2,179,129
12th Dec 2025 (Fri) 9.90 9.90 9.90 9.90 870,115
11th Dec 2025 (Thu) 9.90 10.20 9.90 9.90 533,433
10th Dec 2025 (Wed) 9.80 9.90 9.80 9.90 1,238,355
9th Dec 2025 (Tue) 10.40 10.40 9.80 9.80 1,485,832
8th Dec 2025 (Mon) 9.95 10.25 9.95 10.25 2,272,707
5th Dec 2025 (Fri) 9.75 9.95 9.75 9.95 1,737,810
4th Dec 2025 (Thu) 9.75 9.75 9.75 9.75 962,127
3rd Dec 2025 (Wed) 9.66 9.75 9.65 9.75 692,944
2nd Dec 2025 (Tue) 9.65 9.65 9.65 9.65 565,325
See more Scancell Holdings price history

Scancell Holdings (SCLP) Regulatory News

Date Source Headline
9th Dec 2025 7:00 am RNS Continued improvement in PFS with iSCIB1+
7th Nov 2025 7:00 am RNS Research Update
30th Oct 2025 3:30 pm RNS Result of AGM
3rd Oct 2025 7:00 am RNS Notice of AGM
16th Sep 2025 7:00 am RNS Director Dealing
11th Sep 2025 7:00 am RNS Final Results
4th Sep 2025 7:00 am RNS Notice of Results
8th Aug 2025 12:31 pm RNS Director Dealing
4th Aug 2025 10:23 am RNS Director/PDMR Shareholding
22nd Jul 2025 7:00 am RNS Strong Phase 2 data on iSCIB1+ in Melanoma
See more Scancell Holdings regulatory news

Scancell Holdings (SCLP) Share News

UK shareholder meetings calendar - next 7 days

23rd Oct 2025 14:28

Read More

TRADING UPDATES: Gfinity's Yentra partners with ESG Institute

17th Sep 2025 06:55

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell Holdings notes "tough" macro-environment as loss widens

11th Sep 2025 12:06

(Alliance News) - Scancell Holdings PLC on Thursday said it has made "strong progress" over the last 18 months, but noted impacts from the "tough macroeconomic environment", as it posted a wider full-year loss. Read More

TRADING UPDATES: Scancell reports positive data from melanoma trial

23rd Jul 2025 16:47

(Alliance News) - The following is a round-up of updates and earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Scancell partners with NHS to fast-track melanoma vaccine trial

14th Apr 2025 14:02

(Alliance News) - Scancell Holdings PLC on Monday said it has partnered with the NHS Cancer Vaccine Launch Pad, to accelerate patient recruitment into the fourth cohort of its phase 2 scope study for a targeted melanoma vaccine. Read More

See more Scancell Holdings news
FTSE 100 Latest
Value9,951.14
Change19.76

Login to your account

Forgot Password?

Not Registered